Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Optic Neuritis (TONE)
NCT01962571Phase 3Completed
- Sponsor
- University Eye Hospital Freiburg
- Start
- Nov 2014
- Primary completion
- Jun 2018
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in optic neuritis (ON), sponsored by University Eye Hospital Freiburg. Started Nov 2014; status: completed.
02
Drugs
epoetin alfa
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT01962571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01962571.